A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Elsevier, 2005:875–905

Brown P, 2005, Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics, 23, 1123

10.1016/S0891-5520(03)00004-7

10.1086/383320

10.1128/AAC.37.5.1073

10.1016/S0732-8893(02)00417-0

10.2165/00003495-200262010-00002

10.1128/AAC.37.3.483

10.1172/JCI200316814

Chien SC, 1998, Antimicrob Agents Chemother, 42, 885, 10.1128/AAC.42.4.885

Gotfried MH, 2001, Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest, 119, 1114

10.1001/jama.283.12.1583

10.1016/j.ijantimicag.2003.09.002

10.1086/377539

10.1086/511159

10.2307/2530862